Jacinda Ristov, Pascal Espie, Peter Ulrich, Denise Sickert, Thierry Flandre, Mirela Dimitrova, Dorothee Müller-Ristig, Doris Weider, Gautier Robert, Patrick Schmutz, Barbara Greutmann, Francisco Cordoba-Castro, Martin A Schneider, Max Warncke, Frank Kolbinger, Serge Cote, Christoph Heusser, Christian Bruns, James S Rush
The CD40-CD154 co-stimulatory pathway is essential for T cell-dependent immune responses, development of humoral memory and antigen presenting cell function. These immune functions have been implicated in the pathology of multiple autoimmune diseases as well as allograft rejection. We have generated CFZ533, a fully human, pathway blocking anti-CD40 monoclonal antibody that has been modified with a N297A mutation to render it unable to mediate Fcγ-dependent effector functions. CFZ533 inhibited CD154-induced activation of human leukocytes in vitro, but failed to induce human leukocyte activation...
April 17, 2018: American Journal of Transplantation